QIAGEN (NASDAQ:QGEN) is one of today's notable stocks on the rise, up 4.3% to $16.36. The S&P is trading fractionally higher to 1,315 and the Dow is trading fractionally lower to 12,672.
QIAGEN (NASDAQ:QGEN) has potential upside of 4.7% based on a current price of $16.36 and analysts' consensus price target of $17.12. The stock should discover initial support at its 200-day moving average (MA) of $16.32 and subsequent support at its 50-day MA of $14.30.
In the past 52 weeks, QIAGEN share prices have been bracketed by a low of $12.47 and a high of $22.20 and are now at $16.36, 31% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has slid 0.4%.
QIAGEN N.V. provides technologies for separating and purifying DNA and RNA. The Company's portfolio consists of consumable products for nucleic acid separation, purification, and handling and nucleic acid amplification, as well as automated instrumentation and related services.
